Myovant Sciences Ltd. Quarterly Marketable Securities, Current in USD from Q1 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Myovant Sciences Ltd. quarterly Marketable Securities, Current history and growth rate from Q1 2019 to Q4 2022.
  • Myovant Sciences Ltd. Marketable Securities, Current for the quarter ending December 31, 2022 was $23.8M, a 65.9% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $23.8M -$46.2M -65.9% Dec 31, 2022 10-Q 2023-01-26
Q3 2022 $29.3M -$68.5M -70% Sep 30, 2022 10-Q 2022-10-26
Q2 2022 $31.2M -$53.6M -63.2% Jun 30, 2022 10-Q 2022-07-27
Q1 2022 $27.5M +$17M +163% Mar 31, 2022 10-Q 2023-01-26
Q4 2021 $70M +$37.7M +117% Dec 31, 2021 10-Q 2022-01-26
Q3 2021 $97.8M +$80.8M +473% Sep 30, 2021 10-Q 2021-10-26
Q2 2021 $84.8M +$69.9M +467% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 $10.4M +$7.44M +248% Mar 31, 2021 10-K 2022-05-11
Q4 2020 $32.3M +$16.5M +104% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 $17.1M -$10.1M -37.2% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $15M Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $3M +$3M Mar 31, 2020 10-K 2021-05-11
Q4 2019 $15.8M Dec 31, 2019 10-Q 2020-02-10
Q3 2019 $27.2M Sep 30, 2019 10-Q 2019-11-12
Q1 2019 $0 Mar 31, 2019 10-K 2020-05-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.